Clinical Trials List
Protocol Number12917
2009-09-01 - 2018-07-31
Phase III
Suspended3
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Tzeon-jye Chiou Division of Hematology & Oncology
- Yi-Hsiang Huang Digestive System Department
- Chien-Wei Su Digestive System Department
- Yee Chao Digestive System Department
- Ming-Huang Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Yi-Cheng Chen Digestive System Department
- Wei-Chen Lee Division of General Surgery
- Chau-Ting Yeh Digestive System Department
- 呂嘉偉 Division of Radiation Therapy
- Chao-Wei Hsu Digestive System Department
- Tsai-Sheng Yang Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
- Shi-Ming Lin Digestive System Department
- Ming-Chin Yu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 陳威宇 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Suspended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
910 participants
